Craft

Biotage

Stock Price

KR161.8

2024-10-29

Market Capitalization

KR13.3 B

2024-10-29

Revenue

KR2.1 B

FY, 2024

Biotage Summary

Company Summary

Overview
Biotage is a life science company that provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification. The Company offers systems and consumables within organic chemistry for the development of new pharmaceuticals, such as traditional medicines based on small molecules and medicines based on biomolecules, as well as systems for evaporation. It also provides systems and consumables within analytical chemistry that are used to assist the analysis of samples, including blood, urine, soil, water and food. It sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions. 
Type
Public
Status
Active
Founded
1997
HQ
Uppsala, SE | view all locations
Website
http://www.biotage.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Torben Jörgensen

    Torben Jörgensen, Chairman

    • Tomas Blomquist

      Tomas Blomquist, President and CEO

      • Mark Bradley

        Mark Bradley, Director

        • Peter Ehrenheim

          Peter Ehrenheim, Director

          LocationsView all

          12 locations detected

          • Uppsala, Uppsala län HQ

            Sweden

            5 Vimpelgatan

          • Charlotte, NC

            United States

            10430 Harris Oaks Blvd suite c

          • Salem, NH

            United States

            16 Northwestern Dr

          • San Jose, CA

            United States

            3670 Charter Park Dr suite a

          • Shanghai Shi

            China

            2555 Xiupu Rd, Pudong Xinqu

          • New Delhi, DL

            India

            211, Dlf Tower B, Vishwasji Sadak, Jasola Vihar

          and 6 others

          Biotage Financials

          Summary Financials

          Revenue (Q1, 2025)
          kr385.0M
          Gross profit (Q1, 2025)
          kr282.0M
          Net income (Q1, 2025)
          kr4.0M
          Cash (Q1, 2025)
          kr420.0M
          EBIT (Q1, 2025)
          (kr12.0M)
          Enterprise value
          $13.1B

          Footer menu